Dan R. Littman insider trades

Open-market stock purchases and sales by Dan R. Littman, Director at Pfizer Inc, from SEC Form 4 filings since Mar 5, 2018.

Recent trades

DateStockTradeValue
Apr 23, 2026PFE Pfizer IncBought (not open market)$205K

Companies traded

  • PFE Pfizer Inc: other filings, last Apr 23, 2026

Get free alerts when Dan R. Littman files a new trade →